$50.24

-0.60 (-1.18%)

7/8/2008 4:02 PM

Varian Medical Systems, Inc. (VAR)

CAPS Rating:

The Company designs, manufactures, sells and services advanced equipment and software products for treating cancer with radiation.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating VAR

Add Stock to Watchlist

What the Community Thinks

Total Players

219 Outperforms

10 Underperforms

All-Stars

92 Outperforms

5 Underperforms

Wall Street

11 Outperforms

1 Underperforms

Players bullish on VAR are also bullish on:

Players bearish on VAR are also bearish on:

Ticker Tags

Mid Cap (670), Equipment (65), S&P 500 (482), Medical Appliances & Equipment (106)
Suggest a tag

Varian Medical Systems, Inc. At A Glance

Current Price:	$50.24
Last Trade Time:	7/8/2008 4:02 PM
Open:	$51.01
Previous Close:	$50.84
Daily Range:	$49.79 - $51.16
52-Week Range:	$37.30 - $54.71
Volume:	2,596,654
Market Cap:	$6.39B
P/E Ratio:	24.92
Compare Our Special Broker Offers!

Stock Trends

VAR VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for VAR

Closing Glance: Health Care equipment and supplies
7/8/2008 4:51:00 PM - AP
Opening Glance: Health Care equipment and supplies
7/8/2008 10:49:00 AM - AP
Closing Glance: Health Care equipment and supplies
7/7/2008 4:11:00 PM - AP
Opening Glance: Health Care equipment and supplies
7/7/2008 10:23:00 AM - AP

More Headlines...

Top Bull Pitch

Recs

2 Varian Medical Systems, Inc. (VAR)

Avatar mkeszler (99.48) Submitted: 7/11/07 1:04 PM

With the aging of the population and longer life expectancy, cancer and it's treatment will continue to be a growth industry. Trust me, I'm a doctor....(ha ha) But seriously, these guys are leaders in their field, make more sophisticated devices to better target radiation treatment and limit damage ...More

Replies: 1 | Reply | Permalink

Top Bear Pitch

Recs

6 Varian Medical Systems, Inc. (VAR)

Avatar PauvrePapillon (99.94) Submitted: 10/19/07 1:02 PM

Varian may have current market share but their technology has been rendered obsolete by the commercial introduction of Accuray's CyberKnife. This is why Varian's sales have flattened out. Even Varian's hack analyst Amit Hazan admits as much in his latest excuse as to why VAR has not performed as he ...More

Replies: 14 | Reply | Permalink

Varian may have current market share but their technology has been rendered obsolete by the commercial introduction of Accuray's CyberKnife. This is why Varian's sales have flattened out. Even Varian's hack analyst Amit Hazan admits as much in his latest excuse as to why VAR has not performed as he had predicted.

"'Competitor innovation and subsequent inroads have clearly brought on share losses during the past year, and perhaps caught Varian a little off guard,' Hazan said."

http://72.14.253.104/search?q=cache:tYoEn9oDLK8J:biz.yahoo.com/ap/070611/varian_ahead_of_the_bell.html%3F.v%3D1+%22amit+hazan%22+caught+Varian&hl=en&ct=clnk&cd=1&gl=us

Even Varian’s own press releases reveal an awareness of the problem. First they tout the SRS capabilities of their existing product line. Then they announce a joint venture with BrainLab to develop an SRS machine. If they already have an SRS capable product, why do they need to partner with a competitor to create one? Read between the lines. Varian is in trouble.

http://biz.yahoo.com/prnews/070712/aqth082.html?.v=14

Until recently, CyberKnife has been a self referral-driven phenomenon. Patients see a TV news report or documentary or, doing their own research, find out about CyberKnife on the Internet and start to ask the right questions. The CyberKnife Society and CyberKnife Coalition have taken the lead in helping patients gain access to CyberKnife SRS with Accuray reporting that 95 percent of all cases are achieving reimbursement.

http://www.cyberknifesupport.org/forum/default.aspx?f=16&m=14240

The bottom line for hospitals is that they must adapt or lose the business. Since, the reimbursement rate per fraction for CyberKnife SRS is up to nine times greater than conventional radiotherapy, it’s not a tough sell. As Varian’s existing installed base reaches the point at which this equipment would normally be replaced, hospitals are, instead, opting to upgrade to CyberKnife.

http://seekingalpha.com/article/48192-jefferies-strongly-worded-call-should-push-accuray-higher?source=yahoo

This market is moving towards CyberKnife SRS and way from conventional radiotherapy because CyberKnife gets better results for the patient and is more profitable for the provider. This is not good news for Varian shareholders. If Varian can’t make up for their technology deficit in the radiation oncology space with sales in other markets, their stock price has to come down.

CAPS Players

Show Me:

Sort by:

picks per page. CHANGE

Results 1 - 5 of 40 : 1 2 3 4 5 Next »

Recs 0 (VAR) richardrogers4 (23.49) Submitted: 6/08/08 12:01 PM : Start Price: $47.77 VAR Score: 12.36 - Dominant market position in the radiation technology space - Demographic trends & international markets provide good growth opportunities. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (VAR) fsc137 (89.32) Submitted: 3/27/08 11:51 AM : Start Price: $47.74 VAR Score: 10.16 Bullish on all robotic surgery. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (VAR) PokerMoneyToo (60.57) Submitted: 3/25/08 12:46 PM : Start Price: $47.71 VAR Score: 11.12 Shift in technology will drive single vendor purchases rather piecemeal. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (VAR) VY100 (97.79) Submitted: 3/13/08 4:59 PM : Start Price: $46.94 VAR Score: 9.04 quant pick Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (VAR) bamused (56.12) Submitted: 12/26/07 10:56 PM : Start Price: $53.00 VAR Score: -9.43 Was hot, now is not. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Results 1 - 5 of 40 : 1 2 3 4 5 Next »

Wall Street

Results 1 - 12 of 12

picks per page. CHANGE Expand All Pitches Collapse All Pitches

Top Pick	Player Name	Player Rating	Start Date	Call	Time Frame	Start Price	Stock Gain	S&P Gain	Score	Pitch
	TrackLazardCapit	66.26	04/10/08		NS	$49.72	+1.05%	-6.05%	+7.10
	TrackJefferies	90.36	03/10/08		NS	$46.94	+7.03%	-2.01%	-9.04
	TrackLeerinkSwan	97.07	01/24/08		NS	$52.49	-4.29%	-4.94%	+0.65
	TrackSoleil	25.77	01/02/08		NS	$53.41	-5.94%	-12.64%	+6.71
	TrackRonBaron	< 20	09/30/07		NS	$41.89	+19.93%	-16.63%	+36.57
	TrackCalyonSec	97.55	07/26/07		NS	$41.78	+20.25%	-14.81%	+35.06
	TrackOppenheimer	< 20	04/27/07		NS	$42.50	+18.21%	-14.68%	+32.89
	TrackNeedham	< 20	01/05/07		NS	$45.00	+11.64%	-9.64%	+21.28
	TrackCitigroup	89.60	10/10/06		NS	$51.49	-2.43%	-5.85%	+3.42
	TrackFirstAlbany	76.93	08/25/06		NS	$52.10	-3.57%	-1.83%	-1.74
	TrackPatDorsey	69.89	08/11/06		3Y	$51.05	-1.59%	+0.15%	-1.74
	TrackJimCramer	83.15	07/13/06		3W	$43.91	+14.42%	+2.72%	+11.69

Results 1 - 12 of 12

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.